Original language | English (US) |
---|---|
Article number | 100401 |
Journal | Kidney Medicine |
Volume | 4 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2022 |
ASJC Scopus subject areas
- Nephrology
- Internal Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Kidney Medicine, Vol. 4, No. 2, 100401, 02.2022.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery
T2 - Non-GFR Determinants and Panel-estimated GFR Performance
AU - Chang, Alex R.
AU - Chen, Jingsha
AU - Grams, Morgan E.
AU - Karger, Amy B.
AU - Inker, Lesley A.
AU - Coresh, Josef
AU - Levey, Andrew S.
N1 - Funding Information: Research idea and study design: ARC, MEG, LAI, JC, ASL; data acquisition: ARC; data analysis/interpretation: ARC, JCh, MEG, LAI, JCo, ASL, ABK; statistical analysis: JCh, JCo; supervision or mentorship: ASL, JCo, MEG. Each author contributed important intellectual content during manuscript drafting or revision and agrees to be personally accountable for the individual's own contributions and to ensure that questions pertaining to the accuracy or integrity of any portion of the work, even one in which the author was not directly involved, are appropriately investigated and resolved, including with documentation in the literature if appropriate. Funding for this work was provided to Dr Chang by NIDDK K23DK106515. Dr Inker and Dr Levey were supported by NIDDK R01DK097020 and R01DK116790-01A1. Dr Grams was supported by NIDDK K24HL15586. Dr Karger has received research support from Siemens and is a consultant for Roche Diagnostics. Dr Levey receives research support from Siemens. The remaining authors declare that they have no relevant financial interests. We thank Avry Chagnac for reviewing a draft of this article. Received May 26, 2021, as a submission to the expedited consideration track with 3 external peer reviews. Direct editorial input from an Editorial Board member (Lorien Dalrymple, MD, MPH) who served as Acting Editor-in-Chief. Accepted in revised form October 29, 2021. The involvement of an Acting Editor-in-Chief was to comply with Kidney Medicine's procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies. Funding Information: Funding for this work was provided to Dr Chang by NIDDK K23DK106515. Dr Inker and Dr Levey were supported by NIDDK R01DK097020 and R01DK116790-01A1. Dr Grams was supported by NIDDK K24HL15586.
PY - 2022/2
Y1 - 2022/2
UR - http://www.scopus.com/inward/record.url?scp=85123678696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123678696&partnerID=8YFLogxK
U2 - 10.1016/j.xkme.2021.10.013
DO - 10.1016/j.xkme.2021.10.013
M3 - Article
C2 - 35243311
AN - SCOPUS:85123678696
SN - 2590-0595
VL - 4
JO - Kidney Medicine
JF - Kidney Medicine
IS - 2
M1 - 100401
ER -